There was a significant trend toward longer survival rates in patients with GTR, where the median survival rate was 15.0 months (HR 1.579, 95% CI 0.730-3.414), versus 9.5 months in other patients (HR 0.633, 95%CI 0.292-1.369); p=0.036, df=1 (Figure 7 ).
← all excerpts
Breast Cancer Brain Metastases: A Neurosurgical Point of View From a Single-Center Experience.
1
—
—